About
Mun Ching Lee is Director of Business Development and Marketing at MABPLEX USA, INC, a CDMO providing services to pharmaceutical and biotech companies. Her prior experience includes roles at CL Biologics, Sano Genetics, and GenScript, as well as several biotech startups focused on lab automation and life sciences, spanning sales, marketing, business development, and fundraising. She holds a PhD, serves on the editorial team of the Open Biomedical Initiative, and has participated in iGEM competitions.
Cofounder at Nanovery
Intro paths
→
In turn, Mun can intro founders to Nanovery's investors below.
Nanovery's investors · 2
Co-founders at Nanovery
JK
Jerzy KozyraCEO
Experience
- MABPLEX USA, INCDirector of Business Development and Marketingcurrent2025 — present
- CL BiologicsDirector of Business Development2022 — 2024Greater London, England, United Kingdom
- Sano GeneticsCommercial/Sales Manager2021 — 2022
- GenScriptSales Account Manager (London and Cambridge)2020Greater London, England, United Kingdom
- AutunoCo-Founder2017 — 2020London Area, United Kingdom
- NanoveryCEO and Co-founder of Nanovery2018 — 2019
- Entrepreneur FirstEF LD 11 cohort member2018 — 2019London Area, United Kingdom
- SparrhoB2B Marketing Manager2018
- iGEM KentAdvisor2014 — 2016Kent, United Kingdom
- iGEM EdinburghBiologist (Team Member)2011Greater Edinburgh Area
Skills & more
Commercial Development3Relationship Building5Forecasting5Communication4Business Planning2Pharmaceutical Industry4Antibody Engineering3Life Sciences19Business Development5Sales4Business Strategy1Research23
+12 more
Molecular BiologyBiochemistryGeneticsBiotechnologyPCRProject ManagementConfocal MicroscopyCell BiologyRGoogle AnalyticsMicrosoft OfficeMicrosoft OutlookLanguages Cantonese · English · German · Italian · Malay
- Google Digital Marketing and E-Commerce Professional Certificate — Coursera
- Revenue leadership — Sales Impact Academy
- Go-To market fundamentals — Sales Impact Academy
- Prospecting Through Sequences — Sales Impact Academy
- Introduction to Genomic Technologies — Coursera
From Mun's professional profile.
Frequently asked questions
- Who is Mun Ching Lee?
- Mun Ching Lee is Director of Business Development and Marketing at MABPLEX USA, INC, a CDMO providing services to pharmaceutical and biotech companies. Her prior experience includes roles at CL Biologics, Sano Genetics, and GenScript, as well as several biotech startups focused on lab automation and life sciences, spanning sales, marketing, business development, and fundraising. She holds a PhD, serves on the editorial team of the Open Biomedical Initiative, and has participated in iGEM competitions.
- Where does Mun Ching Lee work?
- Mun Ching Lee is Cofounder of Nanovery.
- What companies did Mun Ching Lee found?
- Mun Ching Lee founded Nanovery.
- Where did Mun Ching Lee go to school?
- Mun Ching Lee studied at The University of Edinburgh (Bachelor of Science (BSc), Biotechnology); University of Kent (Doctor of Philosophy (Ph.D.), Pharmacology); International School of Advanced Studies (SISSA, Italy) (Master of Philosophy (MPhil), Neurobiology).
Same school
Also attended The University of Edinburgh317
Abraham BachrachCo-founder & CTO of SkydioSofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiKevin JohnsonInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalSarah MandersonLegal Director at Hoxton Ventures
+ 311 more
Also attended University of Kent49
Adam MargolinInvestor at Spectrum EquityOliver HammondPartner at Fuel VenturesMax Marley-MurayHead of HR and Recruiting at CaladanStuart CookIndustry Partner at Stack AssetWei Yuan NgFinance and Fund Operations Manager at Ion PacificBrian SalvittiPartner Head of Origination at Aquarian Holdings
+ 43 more
Shared employers
Also worked at Sano Genetics3
Also worked at GenScript1
Also worked at Nanovery1
Also worked at Entrepreneur First688
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockAravind SrinivasCo-founder & CEO of Perplexity AIToby CoppelCo-founder and Partner at Mosaic VenturesBenedict EvansWrites a weekly technology newsletter read by close to 200,000 peoplePeterDeep Tech Investment Lead at Hummingbird VenturesAniTalent Team at Hummingbird Ventures
+ 682 more